Related references
Note: Only part of the references are listed.Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
Jeanne Tie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
Caixia Dong et al.
CHINESE JOURNAL OF CANCER RESEARCH (2021)
Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study
E. A. Agger et al.
BRITISH JOURNAL OF SURGERY (2020)
Does Adjuvant Chemotherapy Improve Survival in T3N0 Rectal Cancer? An Evaluation of Use and Outcomes from the National Cancer Database (NCDB)
Thais Reif de Paula et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Circumferential Resection Margin as a Hospital Quality Assessment Tool for Rectal Cancer Surgery
Sameer H. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Immunotherapy, Inflammation and Colorectal Cancer
Charles Robert Lichtenstern et al.
CELLS (2020)
Nomogram for predicting overall survival in stage II-III colorectal cancer
Jungang Liu et al.
CANCER MEDICINE (2020)
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia
Stephanie G. Craig et al.
BRITISH JOURNAL OF CANCER (2020)
Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin
Jong Yun Baek et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Z. Zheng et al.
COLORECTAL DISEASE (2020)
A new fat-dissociation method to detect lymph nodes in colorectal cancer: a prospective randomized study
Shiki Fujino et al.
SCIENTIFIC REPORTS (2020)
Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk-stratification system based on population analyses
Yun-xia Huang et al.
CANCER MEDICINE (2019)
Three-versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project
J. Souglakos et al.
ANNALS OF ONCOLOGY (2019)
Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes
Guifang Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
Wenhao Zhou et al.
JOURNAL OF CANCER (2019)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
Toshiaki Watanabe et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
AJCC 8th Edition: Colorectal Cancer
Martin R. Weiser
ANNALS OF SURGICAL ONCOLOGY (2018)
Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy
Lei Liang et al.
ONCOTARGET (2016)
The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients
Shidong Hu et al.
PLOS ONE (2016)
An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer
Y. Takakura et al.
Colorectal Disease (2015)
Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas
Jae Ri Kim et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer
Tetsuro Ikeya et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer
Yasuhito Iseki et al.
PLOS ONE (2015)
Surveillance, Epidemiology, and End Results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer
Luke C. Peng et al.
CANCER EPIDEMIOLOGY (2014)
The prognostic value of the number of lymph nodes removed in patients with node-negative colorectal cancer
Nuvit Duraker et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Glimelius et al.
ANNALS OF ONCOLOGY (2013)
Should quality measures for lymph node dissection in colon cancer be extrapolated to rectal cancer?
Travis B. Kidner et al.
AMERICAN JOURNAL OF SURGERY (2012)
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas
S. Fritz et al.
BRITISH JOURNAL OF SURGERY (2011)
Standard protocol for assessment of colon cancer improves the quality of pathology
P. Buchwald et al.
COLORECTAL DISEASE (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Perineural Invasion in Cancer A Review of the Literature
Catherine Liebig et al.
CANCER (2009)
Perineural Invasion: Identification, Significance, and a Standardized Definition
Martin Dunn et al.
DERMATOLOGIC SURGERY (2009)
The importance of accurate pathological assessment of lymph node involvement in colorectal cancer
J. B. Schofield et al.
COLORECTAL DISEASE (2006)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer
L Sarli et al.
EUROPEAN JOURNAL OF CANCER (2005)
Share Paper
